No abstract

Anaferon (pediatric formulation) administered in the therapeutic-and-prophylactic regimen to mice receiving intranasally 100% infecting dose of A/California/07/2009(H1N1)v influenza virus exhibited an antiviral effect and 10-fold reduced the production of influenza virus in the lungs of infected mice on days 4, 6, and 8 after infection compared to the control (distilled water). The efficiency of Anaferon (pediatric formulation) administered before and after infection with A/California/07/2009(H1N1)v influenza virus was not inferior to the use of Tamiflu after infection.

In premature neonates with the respiratory distress syndrome the vessels of the pulmonary arterial system show stereotypical changes: dystonia with the predominance of vasoconstriction, a thickened muscular layer, and a narrowed lumen. A morphometric index is proposed: the coefficient of nonuniformity of the medial thickness of the vascular wall, which reflects a structural reorganization of the pulmonary vessels in different pathological processes.

No abstract